Boothbay Fund Management, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$13.16 - $22.9 $592,200 - $1.03 Million
-45,000 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$19.53 - $25.5 $878,850 - $1.15 Million
45,000 New
45,000 $1.03 Million
Q1 2019

May 15, 2019
SELL
$24.76 - $31.66 $272,360 - $348,260
-11,000 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$24.11 - $31.34 $265,210 - $344,740
11,000 New
11,000 $296,000

Others Institutions Holding RYTM

# of Institutions
178
Shares Held
69.1M
Call Options Held
467K
Put Options Held
224K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $2.69B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email